CLDN1 and Alzheimer disease: While all AD samples showed reduced claudin-1 stainings, the patterns of ZO-1 and occludin stainings were quite heterogenous among the samples (Fig. 3c), which, in turn, might influence the extent of dysfunctional barriers.